Vident Investment Advisory’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-33,195
| Closed | -$1.96M | – | 939 |
|
|
2018
Q1 | $1.96M | Buy |
33,195
+8,886
| +37% | +$526K | 0.08% | 312 |
|
|
2017
Q4 | $1.21M | Buy |
24,309
+11,860
| +95% | +$588K | 0.05% | 353 |
|
|
2017
Q3 | $947K | Buy |
12,449
+377
| +3% | +$28.7K | 0.05% | 371 |
|
|
2017
Q2 | $1.14M | Buy |
12,072
+1,457
| +14% | +$137K | 0.09% | 310 |
|
|
2017
Q1 | $843K | Buy |
10,615
+1,769
| +20% | +$140K | 0.08% | 321 |
|
|
2016
Q4 | $737K | Buy |
8,846
+3,564
| +67% | +$297K | 0.09% | 307 |
|
|
2016
Q3 | $591K | Hold |
5,282
| – | – | 0.08% | 327 |
|
|
2016
Q2 | $586K | Sell |
5,282
-12,300
| -70% | -$1.36M | 0.08% | 359 |
|
|
2016
Q1 | $1.84K | Buy |
17,582
+8,205
| +88% | +$858 | 0.11% | 315 |
|
|
2015
Q4 | $756K | Buy |
+9,377
| New | +$756K | 0.1% | 341 |
|